Principia Wealth Advisory’s BridgeBio Pharma BBIO Stock Holding History

Principia Wealth Advisory’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$670	Hold	9	–	–	﹤0.01%	841
2026 Q1	$668	Buy	9 +6	+200%	+$435	﹤0.01%	795
2025 Q4	$229	Buy	3 +1	+50%	+$66	﹤0.01%	915
2025 Q3	$104	Buy	+2	New	+$98	﹤0.01%	929

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Principia Wealth Advisory's BBIO Position: Q2 2026 in Review

Principia Wealth Advisory held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 9 shares worth $670. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Principia Wealth Advisory first reported a position in BBIO in Q3 2025 and has held it in 4 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

Principia Wealth Advisory held 9 shares of BridgeBio Pharma worth $670 as of Q2 2026.
Principia Wealth Advisory left its BridgeBio Pharma share count unchanged in Q2 2026.
BridgeBio Pharma made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #841 holding.
Principia Wealth Advisory first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 4 quarters since.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.